2016 American Transplant Congress
Subclinical Cytomegalovirus Viraemia in Renal Transplant Recipients.
Background: Studies suggest low-level cytomegalovirus (CMV) viraemia, detected with sensitive molecular assays, may lead to poorer graft outcomes following renal transplantation.Aims: Investigate the incidence, outcomes,…2016 American Transplant Congress
Significant Association of Innate Immune Related Genes Polymorphism on Infectious Complications Following Early Post Renal Transplantation phase.
Department of Gastroenrological and Transplant Surgery, Hiroshima University, Hiroshima, Japan.
ObjectiveInfectious complication is the leading cause of graft dysfunction and patient loss after renal transplantation (RT). In the early post-transplant phase where acquired immunity is…2016 American Transplant Congress
Evaluation of Patient-Reported Nonadherence with Tacrolimus Level Variability in Renal Transplant Recipients.
Medication nonadherence (NA) continues to be a major cause of graft loss post-transplant. Several methods for prospective adherence monitoring have been described including patient interview…2016 American Transplant Congress
Impact of the Kidney Allocation System with Deceased Donor Kidney Transplantation: A Single Center Experience.
University of Virginia Health System, Charlottesville, VA.
Background: In December 2014, UNOS implemented broad sweeping changes in the new Kidney Allocation System (KAS). Recent summary reports by UNOS suggest that nationally, key…2016 American Transplant Congress
Role of Cardiac Evaluation and Management in Kidney and Liver Transplant Candidates.
Cardiac evaluation and risk stratification prior to kidney and liver transplantation can be critical to patient selection and outcomes.Methods: We assessed the impact of cardiac…2016 American Transplant Congress
Impact of Morbid Obesity on Breakthrough CMV Infection in Kidney Transplant Recipients.
Medical University of South Carolina, Charleston, SC.
Purpose: The aim of this study was to assess the impact of obesity on risk for cytomegalovirus (CMV) infection after kidney transplantation as well as…2016 American Transplant Congress
Survival Benefit of Living Donor ABOi Kidney Transplantation.
A recent editorial in AJT characterized ABOi transplants as "Twice as Expensive, Half as Good" and challenged the ABOi community to evaluate survival benefit of…2016 American Transplant Congress
Prospective Randomized OPEN Trial Designed to Reduce the Incidence of Cytomegalovirus (CMV) Infection in DE NOVO Kidney Transplant Recipients Two-Year Results.
Transplant, Hospital Geral de Fortaleza, Fortaleza, CE, Brazil.
Introduction: CMV infection is a frequent complication following organ transplantation, and is associated with inferior long-term patient and graft survival. Here we report the results…2016 American Transplant Congress
Efficacy and Renal Function in Kidney Transplant Recipients Receiving Tacrolimus (TAC)-Based Immunosuppressive Regimens in Combination with Everolimus (EVR) versus Mycophenolate (MPA).
Nephrology Division, Hospital do Rim - UNIFESP, Sao Paulo, Brazil.
Acute rejection and renal function are associated with long-term renal allograft survival. We evaluated these outcomes in patients receiving reduced TAC exposure combined with EVR…2016 American Transplant Congress
Crisis on the Waiting List for Children Listed in Low Volume Solid Organ Transplant Centers.
Department of Abdominal Transplantation, Baylor College of Medicine, Houston, TX.
Purpose: In a recent analysis, we demonstrated that children listed in low volume liver transplant centers had poor waitlist survival and a depressed transplant rate…
- « Previous Page
- 1
- …
- 410
- 411
- 412
- 413
- 414
- …
- 531
- Next Page »